Dechra Pharmaceuticals PLC 1PK.F Stock
Dechra Pharmaceuticals PLC Price Chart
Dechra Pharmaceuticals PLC 1PK.F Financial and Trading Overview
| Dechra Pharmaceuticals PLC stock price | 44.4 EUR |
| Previous Close | 42.6 EUR |
| Open | 42.2 EUR |
| Bid | 41.8 EUR x 70000 |
| Ask | 42.8 EUR x 60000 |
| Day's Range | 42.2 - 42.2 EUR |
| 52 Week Range | 27.4 - 44.8 EUR |
| Volume | 8 EUR |
| Avg. Volume | 18 EUR |
| Market Cap | 4.85B EUR |
| Beta (5Y Monthly) | 0.794636 |
| PE Ratio (TTM) | 100.4762 |
| EPS (TTM) | 0 EUR |
| Forward Dividend & Yield | 0.52 (1.25%) |
| Ex-Dividend Date | March 9, 2023 |
| 1y Target Est | N/A |
1PK.F Valuation Measures
| Enterprise Value | 5.17B EUR |
| Trailing P/E | 100.4762 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 6.6704216 |
| Price/Book (mrq) | 5.670519 |
| Enterprise Value/Revenue | 7.118 |
| Enterprise Value/EBITDA | 39.825 |
Trading Information
Dechra Pharmaceuticals PLC Stock Price History
| Beta (5Y Monthly) | 0.794636 |
| 52-Week Change | 19.31% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 44.8 EUR |
| 52 Week Low | 27.4 EUR |
| 50-Day Moving Average | 38.94 EUR |
| 200-Day Moving Average | 33.1 EUR |
1PK.F Share Statistics
| Avg. Volume (3 month) | 18 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 113.89M |
| Float | 112.54M |
| Short Ratio | N/A |
| % Held by Insiders | 0.87% |
| % Held by Institutions | 88.53% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.454 |
| Trailing Annual Dividend Yield | 1.06% |
| 5 Year Average Dividend Yield | 112.00% |
| Payout Ratio | 1.2511001 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 5.51% |
| Operating Margin (ttm) | 11.73% |
| Gross Margin | 57.04% |
| EBITDA Margin | 17.87% |
Management Effectiveness
| Return on Assets (ttm) | 3.64% |
| Return on Equity (ttm) | 5.41% |
Income Statement
| Revenue (ttm) | 726.8M EUR |
| Revenue Per Share (ttm) | 6.56 EUR |
| Quarterly Revenue Growth (yoy) | 13.50% |
| Gross Profit (ttm) | 384.8M EUR |
| EBITDA | 129.9M EUR |
| Net Income Avi to Common (ttm) | 40.1M EUR |
| Diluted EPS (ttm) | 0.42 |
| Quarterly Earnings Growth (yoy) | -44.50% |
Balance Sheet
| Total Cash (mrq) | 87.9M EUR |
| Total Cash Per Share (mrq) | 0.78 EUR |
| Total Debt (mrq) | 511.2M EUR |
| Total Debt/Equity (mrq) | 60.73 EUR |
| Current Ratio (mrq) | 2.727 |
| Book Value Per Share (mrq) | 7.442 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 86.3M EUR |
| Levered Free Cash Flow (ttm) | 18.79M EUR |
Profile of Dechra Pharmaceuticals PLC
| Country | Germany |
| State | N/A |
| City | Northwich |
| Address | 24 Cheshire Avenue |
| ZIP | CW9 7UA |
| Phone | 44 1606 814730 |
| Website | https://www.dechra.com |
| Industry | Drug Manufacturers-General |
| Sector(s) | Healthcare |
| Full Time Employees | 1998 |
Dechra Pharmaceuticals PLC develops, manufactures, regulates, markets, and sells veterinary pharmaceuticals and related products for veterinarians. It operates through three segments: European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. The company offers various endocrinology, dermatology, analgesia and anesthesia, cardiovascular, and critical care products for dogs and cats; water soluble antibiotics, poultry vaccines, and pain management for poultry, pigs, and cattle; and lameness and pain management products for horses and ponies. It also provides pet nutrition products for supporting cats and dogs with various therapeutic conditions, such as allergies, obesity, heart, and kidney diseases. In addition, the company distributes veterinary pharmaceuticals and equipment; offers financial services; markets pet diets; and develops, regulates, manufactures, and markets crop protection. It markets its products through wholesaler and distributor networks. The company operates in the United Kingdom, Germany, rest of Europe, the United States, and internationally. Dechra Pharmaceuticals PLC was incorporated in 1997 and is headquartered in Northwich, the United Kingdom.
Q&A For Dechra Pharmaceuticals PLC Stock
What is a current 1PK.F stock price?
Dechra Pharmaceuticals PLC 1PK.F stock price today per share is 44.4 EUR.
How to purchase Dechra Pharmaceuticals PLC stock?
You can buy 1PK.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Dechra Pharmaceuticals PLC?
The stock symbol or ticker of Dechra Pharmaceuticals PLC is 1PK.F.
Which industry does the Dechra Pharmaceuticals PLC company belong to?
The Dechra Pharmaceuticals PLC industry is Drug Manufacturers-General.
How many shares does Dechra Pharmaceuticals PLC have in circulation?
The max supply of Dechra Pharmaceuticals PLC shares is 113.91M.
What is Dechra Pharmaceuticals PLC Price to Earnings Ratio (PE Ratio)?
Dechra Pharmaceuticals PLC PE Ratio is 0.00000000 now.
What was Dechra Pharmaceuticals PLC earnings per share over the trailing 12 months (TTM)?
Dechra Pharmaceuticals PLC EPS is 0 EUR over the trailing 12 months.
Which sector does the Dechra Pharmaceuticals PLC company belong to?
The Dechra Pharmaceuticals PLC sector is Healthcare.